Shandong Lukang Pharmaceutical Co Ltd (600789) — Cash Flow Reinvestment Rate
Shandong Lukang Pharmaceutical Co Ltd (600789) has a Cash Flow Reinvestment Rate of 0.44x as of June 2025, reinvesting CN¥126.25 Million (capex CN¥88.93 Million plus investments CN¥-37.33 Million) from operating cash flow of CN¥285.47 Million. See Shandong Lukang Pharmaceutical Co Ltd (600789) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Lukang Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Shandong Lukang Pharmaceutical Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see how efficiently does Shandong Lukang Pharmaceutical Co Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)
Year-by-year capital reinvestment analysis for Shandong Lukang Pharmaceutical Co Ltd. See Shandong Lukang Pharmaceutical Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | CN¥340.05 Million | CN¥698.17 Million | CN¥338.86 Million | ▼ -63.5% |
| 2024 | 1.34x | CN¥538.05 Million | CN¥402.82 Million | CN¥279.18 Million | ▲ +14.0% |
| 2023 | 1.17x | CN¥707.69 Million | CN¥604.01 Million | CN¥337.91 Million | ▲ +17.2% |
| 2022 | 1.00x | CN¥444.18 Million | CN¥444.38 Million | CN¥428.36 Million | ▼ -71.8% |
| 2021 | 3.54x | CN¥528.93 Million | CN¥149.33 Million | CN¥486.75 Million | ▲ +11.0% |
| 2020 | 3.19x | CN¥748.51 Million | CN¥234.55 Million | CN¥703.12 Million | ▲ +6.1% |
| 2019 | 3.01x | CN¥1.09 Billion | CN¥361.87 Million | CN¥828.61 Million | ▼ -10.7% |
| 2018 | 3.37x | CN¥1.18 Billion | CN¥351.09 Million | CN¥855.24 Million | ▼ -16.3% |
| 2017 | 4.02x | CN¥1.11 Billion | CN¥275.51 Million | CN¥780.71 Million | ▲ +70.4% |
| 2016 | 2.36x | CN¥699.51 Million | CN¥296.23 Million | CN¥371.51 Million | ▼ -71.6% |
| 2015 | 8.31x | CN¥651.58 Million | CN¥78.39 Million | CN¥164.54 Million | ▲ +665.1% |
| 2014 | 1.09x | CN¥117.94 Million | CN¥108.56 Million | CN¥117.94 Million | ▲ +21.0% |
| 2013 | 0.90x | CN¥230.35 Million | CN¥256.50 Million | CN¥230.35 Million | ▼ -63.6% |
| 2012 | 2.47x | CN¥284.40 Million | CN¥115.20 Million | CN¥284.40 Million | ▼ -29.0% |
| 2011 | 3.48x | CN¥428.82 Million | CN¥123.28 Million | CN¥428.82 Million | ▲ +269.6% |
| 2010 | 0.94x | CN¥290.69 Million | CN¥308.88 Million | CN¥290.69 Million | ▲ +169.9% |
| 2009 | 0.35x | CN¥69.57 Million | CN¥199.49 Million | CN¥69.57 Million | ▼ -4.7% |
| 2008 | 0.37x | CN¥76.58 Million | CN¥209.39 Million | CN¥76.58 Million | ▲ +116.0% |
| 2007 | 0.17x | CN¥23.25 Million | CN¥137.30 Million | CN¥23.25 Million | ▼ -56.9% |
| 2006 | 0.39x | CN¥22.12 Million | CN¥56.24 Million | CN¥22.12 Million | ▲ +3.7% |
| 2005 | 0.38x | CN¥61.27 Million | CN¥161.64 Million | CN¥61.27 Million | ▼ -82.0% |
| 2004 | 2.10x | CN¥133.10 Million | CN¥63.24 Million | CN¥133.10 Million | ▲ +96.6% |
| 2003 | 1.07x | CN¥179.25 Million | CN¥167.42 Million | CN¥179.25 Million | ▲ +69.0% |
| 2002 | 0.63x | CN¥199.94 Million | CN¥315.59 Million | CN¥199.94 Million | ▼ -15.8% |
| 2001 | 0.75x | CN¥203.50 Million | CN¥270.43 Million | CN¥203.50 Million | ▼ -93.3% |
| 2000 | 11.21x | CN¥250.64 Million | CN¥22.36 Million | CN¥250.64 Million | ▲ +312.0% |
| 1999 | 2.72x | CN¥95.56 Million | CN¥35.12 Million | CN¥95.56 Million | ▼ -20.0% |
| 1998 | 3.40x | CN¥156.96 Million | CN¥46.18 Million | CN¥156.96 Million | — |